TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership206,538 shares
Latest Disclosed Value $ 6,861,192
IFP Advisors, Inc reports 4.70% increase in ownership of 1TGTX / TG Therapeutics, Inc.

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 206,538 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $5,712,841 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 197,258 shares of TG Therapeutics, Inc.. This represents a change in shares of 4.70% during the quarter. The current value of the position is $7,022,292 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F TG THERAPEUTICS cs 88322Q108 206,538 9,280 4.70 6,861 16.68 0.1423
2026-02-06 2025-12-31 13F TG THERAPEUTICS cs 88322Q108 197,258 312 0.16 5,880 -17.35 0.1320
2026-02-06 2025-09-30 13F/A-1 TG THERAPEUTICS cs 88322Q108 196,946 6,249 3.28 7,115 3.49 0.1848
2025-12-02 2025-09-30 13F TG THERAPEUTICS cs 88322Q108 196,717 6,020 7,123 0.1837
2025-07-24 2025-06-30 13F TG THERAPEUTICS cs 88322Q108 190,697 2,635 1.40 6,874 -7.30 0.1955
2025-05-05 2025-03-31 13F TG THERAPEUTICS cs 88322Q108 188,062 9,515 5.33 7,415 37.98 0.2286
2025-02-04 2024-12-31 13F TG THERAPEUTICS cs 88322Q108 178,547 54,983 44.50 5,374 85.95 0.1760
2025-02-04 2024-09-30 13F TG THERAPEUTICS cs 88322Q108 123,564 123,564 2,890 0.1042
2024-07-30 2024-06-30 13F TG THERAPEUTICS cs 88322Q108 0 -64 -100.00 0 0.0000
2024-07-30 2024-03-31 13F TG THERAPEUTICS cs 88322Q108 64 -36 -36.00 1 -100.00 0.0000
2023-08-14 2023-06-30 13F/A-1 TG THERAPEUTICS cs 88322Q108 100 -1,000 -90.91 2 -85.71 0.0001
2023-08-04 2023-06-30 13F TG THERAPEUTICS cs 88322Q108 100 -1,000 1 0.0001
2023-04-18 2023-03-31 13F TG THERAPEUTICS cs 88322Q108 1,100 -26 -2.31 15 0.0006
2023-02-07 2022-12-31 13F TG THERAPEUTICS cs 88322Q108 1,126 1,015 914.41 0 -100.00 0.0004
2022-11-08 2022-09-30 13F TG THERAPEUTICS cs 88322Q108 111 9 8.82 3 50.00 0.0001
2022-09-06 2022-06-30 13F/A-1 TG THERAPEUTICS cs 88322Q108 102 0 0.00 2 0.00 0.0001
2022-09-06 2022-03-31 13F/A-1 TG THERAPEUTICS cs 88322Q108 102 2 2.00 2 0.00 0.0001
2022-08-08 2022-03-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 100 0 1 0.0000
2022-01-12 2021-12-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 100 0 0.00 2 -33.33 0.0000
2021-10-06 2021-09-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 100 -516 -83.77 3 -88.00 0.0001
2021-07-13 2021-06-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 616 -118 -16.08 25 -30.56 0.0005
2021-04-30 2021-03-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 734 362 97.31 36 80.00 0.0007
2021-01-25 2020-12-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 372 321 629.41 20 900.00 0.0008
2020-10-29 2020-09-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 51 51 2 0.0001
2019-05-15 2019-03-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 0 -750 -100.00 0 -100.00
2019-06-03 2018-12-31 13F/A-10 TG THERAPEUTICS INC COM Stock 88322Q108 750 -1,450 -65.91 3 -75.00 0.0002
2019-01-23 2018-12-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 750 -1,450 3 0.0002
2019-06-03 2018-09-30 13F/A-9 TG THERAPEUTICS INC COM Stock 88322Q108 2,200 200 10.00 12 -53.85 0.0005
2018-10-25 2018-09-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 2,200 200 12 0.0005
2019-06-03 2018-06-30 13F/A-8 TG THERAPEUTICS INC COM Stock 88322Q108 2,000 500 33.33 26 116.67 0.0011
2018-08-07 2018-06-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 2,000 300 26
2019-06-03 2018-03-31 13F/A-7 TG THERAPEUTICS INC COM Stock 88322Q108 1,500 0 0.00 12 0.00 0.0005
2018-05-09 2018-03-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 1,700 200 24
2019-06-03 2017-12-31 13F/A-6 TG THERAPEUTICS INC COM Stock 88322Q108 1,500 -450 -23.08 12 -47.83 0.0005
2018-01-24 2017-12-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 1,500 -450 12
2017-10-30 2017-09-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 1,950 -1,900 -49.35 23 -41.03 0.0009
2019-06-03 2017-06-30 13F/A-5 TG THERAPEUTICS INC COM Stock 88322Q108 3,850 3,850 39 0.0017
2017-07-31 2017-06-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 3,850 3,850 39
2019-06-03 2017-03-31 13F/A-4 TG THERAPEUTICS INC COM Stock 88322Q108 0 -1,000 -100.00 0 -100.00
2019-06-03 2016-12-31 13F/A-3 TG THERAPEUTICS INC COM Stock 88322Q108 1,000 750 300.00 5 150.00 0.0002
2017-02-14 2016-12-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 1,000 750 5
2016-11-04 2016-09-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 250 0 0.00 2 0.00 0.0001
2019-06-03 2016-06-30 13F/A-2 TG THERAPEUTICS INC COM Stock 88322Q108 250 0 0.00 2 0.00 0.0001
2016-08-22 2016-06-30 13F TG THERAPEUTICS INC COM Stock 88322Q108 250 0 2
2016-05-02 2016-03-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 250 -2,000 -88.89 2 -92.59 0.0001
2016-02-11 2015-12-31 13F TG THERAPEUTICS INC COM Stock 88322Q108 2,250 2,250 27 0.0018
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.